Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Correction for Shichiri et al., Hypertension 30 (5) 1198-1203.
Hypertension. 1998;31:723

This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

(Hypertension. 1998;31:723.)
© 1998 American Heart Association, Inc.

Corrections


In the article by Shichiri et al, "Endothelin-1 as an Autocrine/Paracrine Apoptosis Survival Factor for Endothelial Cells" (Hypertension. 1997;30:1198–1203.), Figs 2Down and 4Down were incorrect. The correct figures are shown below.



View larger version (13K):
[in this window]
[in a new window]
 
Figure 2. Flow cytometric DNA analysis of endothelial cells. Rat endothelial cells were serum-deprived for 4 hours, stained with propidium iodide, and subjected to flow cytometric analysis: total endothelial cells cultured in 10% FBS (A), total cultured cells after 4-hour serum starvation (B), and floating cells (C) (4-hour serum starvation) were collected and analyzed. Apoptotic cells with subdiploid DNA staining are cells with subdiploid DNA staining are shown in the region marked with the bar, and the percentage of such cells is indi-cated. Arrowheads indicate the positions of peak G0/G1 cells (left) and G2 cells (right).



View larger version (16K):
[in this window]
[in a new window]
 
Figure 4. ET-1 acts as an apoptosis survival factor for endothelial cells. Exponentially growing rat endothelial cells were changed into serum-free medium containing the indicated concentrations of ET-1. After 24 hours, all floating cells were collected and counted with a Coulter counter. Each point represents mean±SEM (n=6); values were calculated by the percentage of floating cells in the absence of ET-1. *P<.05, **P<.01 for treated versus untreated cells, respectively.

In the article by Weber et al, "Effects of SR 49059, a New Orally Active and Specific Vasopressin V1 Receptor Antagonist, on Vasopressin-Induced Vasoconstriction in Humans" (Hypertension. 1997;30:1121–1127.), an incorrect unit of measure was used. The sentence should read as follows:

The baseline mean diameter was comparable in the three groups (ie, 2876±89 µm in the placebo group and 2744±201 and 2799±175 µm in the 30- and 300-mg SR 49059 groups, respectively).





This Article
Right arrow Extract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content